Running summarizing tools on a new article

Check the paper below, then start its synthesis.


Motor manifestations in PSEN1-Related early-onset Alzheimer’s disease: a case series and systematic review

Mannoela Becker Genz, Ingrid Lorena da Silva Gomes, Filipe Junqueira, Thomas Hugentobler Schlickamnn, Paula Garbarski, Allan Andrew Ahlf, Leonardo Medeiros, Igor Brum, Raphael Castilhos

License: not stated (all rights reserved)

Abstract: Background: Autosomal dominant early-onset Alzheimer’s disease (EOAD) is a distinct subset of dementia, often affecting individuals during their working age. It is most frequently caused by pathogenic variants in PSEN1, accounting for the majority of genetically confirmed cases worldwide. Although typically characterized by amnestic cognitive decline, increasing evidence highlights substantial phenotypic variability among PSEN1 carriers, suggesting manifestations extend beyond the cognitive domain. Motor features, including pyramidal signs, dystonia and parkinsonism, have been reported in different stages of the disease, but are not routinely integrated into the recognized clinical spectrum. This lack of recognition often leads to motor-predominant or mixed presentations being misdiagnosed as other neurodegenerative disorders, delaying diagnosis and counseling. Objective: To characterize the phenotypic diversity of PSEN1-associated EOAD, focusing on the heterogeneity of motor manifestations to improve diagnostic accuracy. Objective: To characterize the phenotypic diversity of PSEN1-associated EOAD, focusing on the heterogeneity of motor manifestations to improve diagnostic accuracy. Methods: Retrospective descriptive case series of three unrelated individuals with confirmed PSEN1-associated EOAD evaluated at a tertiary center. Clinical, neuropsychological, neuroimaging, and genetic data were reviewed. To contextualize these findings, a systematic review was conducted using PubMed, Embase, and Web of Science. Results: The three cases illustrated heterogeneous initial presentations: one patient had a typical cognitive phenotype, while two exhibited early prominent pyramidal and extrapyramidal signs that led to alternative diagnostic considerations. The systematic review analyzed 184 articles describing 458 patients (46.06% male, 41.92% female) with a mean age of ± 37.6 years. Regarding initial symptoms, 10.91% of the patients presented with cognitive decline, 8.95% with purely motor symptoms, and 9.39% with mixed motor-cognitive presentations. Motor dysfunction was highly prevalent: 57.87% of the patients exhibited pyramidal signs, spasticity, or gait disturbances; 30.57% showed rigidity, tremor, or dystonia; 24.45% had cerebellar signs; and 17.69% presented with myoclonus. Specific frequencies included spasticity or spastic paraparesis (22.05%); gait abnormalities (21.61%); parkinsonism (19.87%); increased tonus, brisk reflexes or hyperreflexia (19.43%); ataxia (10.48%) and muscle weakness (5.24%). Motor-related daily life difficulties were reported for 18.12% of the patients. Conclusion: PSEN1-associated EOAD encompasses a broad clinical spectrum in which motor manifestations may precede, accompany, or follow cognitive decline. This original study consolidates previously dispersed clinical data into a unified analysis. Recognizing these features may reduce diagnostic delay and facilitate earlier identification of monogenic disease, with implications for genetic counseling and family management.

Published on 07 Oct. 2026